Periconceptional folate deficiency and implications in neural tube defects

Journal of Pregnancy

Volumn 2012, Issue , 2012, Pages

  Safi, J ^a   Joyeux, L ^b   Chalouhi, G E ^c  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

DIET SUPPLEMENTATION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; MALE; MATERNAL NUTRITION; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; MALE; MATERNAL EXPOSURE; NEURAL TUBE DEFECTS; PATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; VITAMIN B COMPLEX;

EID: 84866245698     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2012/295083     Document Type: Review

References (82)

1. Rosano A., Botto L. D., Botting B., Mastroiacovo P., Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. Journal of Epidemiology and Community Health 2000 54 9 660 666 2-s2.0-0033870813 10.1136/jech.54.9.660 (Pubitemid 30639397)
2. EUROCAT, Surveillance of Congenital Anomalies in Europe, 19801999. E.S.o.C.A. EUROCAT, European surveillance of congenital anomalies: University of Ulster, Newtownabbey, Northern Ireland, 2002
3. Correa-Villaseñor A., Cragan J., Kucik J., O'Leary L., Siffel C., Williams L., The metropolitan atlanta congenital defects program: 35 years of birth defects surveillance at the centers for disease control and prevention. Birth Defects Research Part A 2003 67 9 617 624 2-s2.0-0141864516 10.1002/bdra.10111 (Pubitemid 37222110)
4. Petrini J., Damus K., Russell R., Poschman K., Davidoff M. J., Mattison D., Contribution of birth defects to infant mortality in the United States. Teratology 2002 66 1, supplement S3 S6 2-s2.0-0036393850 10.1002/tera.90002
5. CDC, Periconceptional use of multivitamins and the occurrence of anencephaly and spina bifida. Morbidity and Mortality Weekly Report 1988 37 47 727 730
6. Moore K. L., Persaud T. V. N., The Developing Human: Clinically Oriented Embryology 2003 Philadelphia, Pa, USA Saunders
7. Dolk H., What is the primary prevention of congenital anomalies? The Lancet 2009 374 9687 378 2-s2.0-67651251198 10.1016/S0140-6736(09)61411-2
8. Laurence K. M., James N., Miller M., Campbell H., Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. British Medical Journal 1980 281 6255 1592 1594 2-s2.0-0019176220 (Pubitemid 11253139)
9. Smithells R. W., Sheppard S., Schorah C. J., Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980 1 8164 339 340 2-s2.0-0018922950 (Pubitemid 10219521)
10. Wald N., Sneddon J., Densem J., Frost C., Stone R., Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 1991 338 8760 131 137 2-s2.0-0025863475 10.1016/0140-6736(91)90133-A
11. Czeizel A. E., Dudas I., Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992 327 26 1832 1835 2-s2.0-0027080461 (Pubitemid 23003073)
12. Tolarova M., Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 1982 2 8291 217 2-s2.0-0019985118 (Pubitemid 12080530)
13. Czeizel A. E., Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics 1996 62 2 179 183 10.1002/(SICI)1096-8628(19960315)62:2179::AID- AJMG12>3.0.CO;2-L
14. EUROCAT, Surveillance of Congenital Anomalies in Europe, 19801999. E.S.o.C.A. EUROCAT, European surveillance of congenital anomalies, University of Ulster, Newtownabbey, Northern Ireland, 2002
15. EUROCAT, A Review of Environmental Risk Factors for Congenital Anomalies. E.S.o.C.A. EUROCAT, EUROCAT, European surveillance of congenital anomalies, University of Ulster, Newtownabbey, Northern Ireland, 2004
16. Khulan B., Cooper W. N., Skinner B. M., Bauer J., Owens S., Prentice A. M., Belteki G., Constancia M., Dunger D., Affara N. A., Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: a study of a unique resource in the Gambia. Human Molecular Genetics 2012 21 9 2086 2101 10.1093/hmg/dds026
17. Simpson J. L., Bailey L. B., Pietrzik K., Shane B., Holzgreve W., Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part i Folate, Vitamin B12, Vitamin B6. Journal of Maternal-Fetal and Neonatal Medicine 2010 23 12 1323 1343 2-s2.0-78249283510 10.3109/14767051003678234
18. Joyeux L., Etiopathogenesis and treatment of for congenital malformations curable in utero [medical thesis]. p. 196, June 2011
19. Ngo A. D., Taylor R., Roberts C. L., Paternal exposure to Agent Orange and spina bifida: a meta-analysis. European Journal of Epidemiology 2010 25 1 37 44 2-s2.0-75049083640 10.1007/s10654-009-9401-4
20. Danzer E., Schwarz U., Wehrli S., Radu A., Adzick N. S., Flake A. W., Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging. Experimental Neurology 2005 194 2 467 475 2-s2.0-22044431602 10.1016/j.expneurol.2005.03.011 (Pubitemid 40967004)
21. Danzer E., Radu A., Robinson L. E., Volpe M. V., Adzick N. S., Flake A. W., Morphologic analysis of the neuromuscular development of the anorectal unit in fetal rats with retinoic acid induced myelomeningocele. Neuroscience Letters 2008 430 2 157 162 2-s2.0-37549001045 10.1016/j.neulet.2007.10.048
22. Bailey L. B., Zempleni J., McCormick D. B., Suttie J. W., Folic acid. Handbook of Vitamins 2007 Boca Raton, Fla, USA CRC Press, Taylor & Francis Group 387
23. Ek J., Plasma and red cell folate values in newborn infants and their mothers in relation to gestational age. Journal of Pediatrics 1980 97 2 288 292 2-s2.0-0018897787 (Pubitemid 10056314)
24. Chanarin I., The Megaloblastic Anaemias 1969 London, UK Blackwell
25. Bruinse H. W., Berg V. H. D., Haspels A. A., Maternal serum folacin levels during and after normal pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology 1985 20 3 153 158 2-s2.0-0021815999 (Pubitemid 15015455)
26. Qvist I., Abdulla M., Jagerstad M., Svensson S., Iron, zinc and folate status during pregnancy and two months after delivery. Acta Obstetricia et Gynecologica Scandinavica 1986 65 1 15 22 2-s2.0-0022596152 (Pubitemid 16111732)
27. Tamura T., Picciano M. F., Folate and human reproduction. American Journal of Clinical Nutrition 2006 83 5 993 1016 2-s2.0-33745138548 (Pubitemid 44713098)
28. Takimoto H., Mito N., Umegaki K., Ishiwaki A., Kusama K., Abe S., Yamawaki M., Fukuoka H., Ohta C., Yoshiike N., Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. European Journal of Nutrition 2007 46 5 300 306 2-s2.0-34547199926 10.1007/s00394-007-0667-6 (Pubitemid 47125270)
29. Wallace J. M. W., Bonham M. P., Strain J. J., Duffy E. M., Robson P. J., Ward M., McNulty H., Davidson P. W., Myers G. J., Shamlaye C. F., Clarkson T. W., Molloy A. M., Scott J. M., Ueland P. M., Homocysteine concentration, related B vitamins, and betaine in pregnant women recruited to the Seychelles Child Development Study. American Journal of Clinical Nutrition 2008 87 2 391 397 2-s2.0-38949107356 (Pubitemid 351226076)
30. Talaulikar V. S., Arulkumaran S., Folic acid in obstetric practice: a review. Obstetrical and Gynecological Survey 2011 66 4 240 247 2-s2.0-79961071065 10.1097/OGX.0b013e318223614c
31. De Regil L. M., Fernández-Gaxiola A. C., Dowswell T., Peña-Rosas J. P., Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews 2009 3 2-s2.0-70049108523 10.1002/14651858.CD007950 CD007950
32. Mitchell L. E., Scott Adzick N., Melchionne J., Pasquariello P. S., Sutton L. N., Whitehead A. S., Spina bifida. Lancet 2004 364 9448 1885 1895 2-s2.0-8844265391 10.1016/S0140-6736(04)17445-X (Pubitemid 39536093)
33. CDC, CDC grand rounds: additional opportunities to prevent neural tube defects with folic acid fortification. Morbidity and Mortality Weekly Report 2010 59 31 980 984
34. Wald N., Sneddon J., Densem J., Frost C., Stone R., Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 1991 338 8760 131 137 2-s2.0-0025863475 10.1016/0140-6736(91)90133-A
35. Berry R. J., Li Z., Erickson J. D., Li S., Moore C. A., Wang H., Mulinare J., Zhao P., Wong L. Y. C., Gindler J., Hong S. X., Correa A., Prevention of neural-tube defects with folic acid in China. New England Journal of Medicine 1999 341 20 1485 1490 2-s2.0-0033547440 10.1056/NEJM199911113412001 (Pubitemid 29526350)
36. Kauwell G. P. A., Yang Q., Bailey L. B, Bailey L. B, Folate: recommended intakes, consumption, and status. Folate in Health and Disease 2009 Boca Raton, Fla, USA CRC Press, Taylor and Francis Group 467 490
37. Daly L. E., Kirke P. N., Molloy A., Weir D. G., Scott J. M., Folate levels and neural tube defects: implications for prevention. Journal of the American Medical Association 1995 274 21 1698 1702 2-s2.0-0028863219
38. Cuskelly G. J., McNulty H., Scott J. M., Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996 347 9002 657 659 2-s2.0-0029967412 10.1016/S0140-6736(96)91205-2 (Pubitemid 26076133)
39. Brämswig S., Prinz-Langenohl R., Lamers Y., Tobolski O., Wintergerst E., Berthold H. K., Pietrzik K., Supplementation with a multivitamin containing 800 μ g of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. International Journal for Vitamin and Nutrition Research 2009 79 2 61 70 2-s2.0-76749092706 10.1024/0300-9831.79. 2.61
40. Czeizel A. E., Periconceptional folic acid containing multivitamin supplementation. European Journal of Obstetrics Gynecology and Reproductive Biology 1998 78 2 151 161 2-s2.0-0032104612 10.1016/S0301-2115(98)00061-X (Pubitemid 28201105)
41. Czeizel A. E., Dobó M., Vargha P., Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Research Part A 2004 70 11 853 861 2-s2.0-10044224512 10.1002/bdra.20086 (Pubitemid 39602196)
42. Botto L. D., Mulinare J., Erickson J. D., Occurrence of congenital heart defects in relation to maternal multivitamin use. American Journal of Epidemiology 2000 151 9 878 884 2-s2.0-0034190437 (Pubitemid 30461128)
43. Van Beynum I. M., Kapusta L., Bakker M. K., Den Heijer M., Blom H. J., De Walle H. E. K., Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. European Heart Journal 2010 31 4 464 471 2-s2.0-77249110308 10.1093/eurheartj/ehp479
44. Ionescu-Ittu R., Marelli A. J., Mackie A. S., Pilote L., Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. British Medical Journal 2009 338 b1673 2-s2.0-67449124263 10.1136/bmj.b1673
45. Goh Y. I., Bollano E., Einarson T. R., Koren G., Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. Journal of Obstetrics and Gynaecology Canada 2006 28 8 680 689 2-s2.0-33846788502
46. Hatch M. C., Stein Z. A., Agent Orange and risks to reproduction: the limits of epidemiology. Teratogenesis Carcinogenesis and Mutagenesis 1987 7 4 423 424 2-s2.0-0023067869
47. Giri A. K., Mutagenic and genotoxic effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin. A review. Mutation Research 1986 168 3 241 248 2-s2.0-0022833945 (Pubitemid 17220418)
48. Halwachs S., Lakoma C., Gebhardt R., Schäfer I., Seibel P., Honscha W., Dioxin mediates downregulation of the reduced folate carrier transport activity via the arylhydrocarbon receptor signalling pathway. Toxicology and Applied Pharmacology 2010 246 1-2 100 106 2-s2.0-77953713215 10.1016/j.taap.2010.04.020
49. Hansen D. A., Paternal environmental exposures and gene expression during spermatogenesis: research review to research framework. Birth Defects Research Part C 2008 84 2 155 163 2-s2.0-46949103536 10.1002/bdrc.20121 (Pubitemid 351958433)
50. Schultz R., Suominen J., Värre T., Hakovirta H., Parvinen M., Toppari J., Pelto-Huikko M., Expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator messenger ribonucleic acids and proteins in rat and human testis. Endocrinology 2003 144 3 767 776 2-s2.0-0037370164 10.1210/en.2002-220642 (Pubitemid 36266681)
51. Ray J. G., Goodman J., O'Mahoney P. R. A., Mamdani M. M., Jiang D., High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification. QJM 2008 101 6 475 477 2-s2.0-44849084799 10.1093/qjmed/hcn031 (Pubitemid 351791531)
52. Ray J. G., Blom H. J., Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM 2003 96 4 289 295 2-s2.0-0344837893 10.1093/qjmed/hcg043 (Pubitemid 36432388)
53. Suarez L., Hendricks K., Felkner M., Gunter E., Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Annals of Epidemiology 2003 13 2 81 88 2-s2.0-0037306954 10.1016/S1047-2797(02)00267-3 (Pubitemid 36143706)
54. Ray J. G., Wyatt P. R., Thompson M. D., Vermeulen M. J., Meier C., Wong P. Y., Farrell S. A., Cole D. E. C., Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007 18 3 362 366 2-s2.0-34247218125 10.1097/01.ede.0000257063.77411.e9 (Pubitemid 46624947)
55. Kirke P. N., Molloy A. M., Daly L. E., Burke H., Weir D. G., Scott J. M., Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Quarterly Journal of Medicine 1993 86 11 703 708 2-s2.0-0027145847
56. Molloy A. M., Kirke P. N., Troendle J. F., Burke H., Sutton M., Brody L. C., Scott J. M., Mills J. L., Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009 123 3 917 923 2-s2.0-63149166599 10.1542/peds.2008-1173
57. Zhang T., Xin R., Gu X., Wang F., Pei L., Lin L., Chen G., Wu J., Zheng X., Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutrition 2009 12 5 680 686 2-s2.0-67650354893 10.1017/S1368980008002735
58. (IOM), I.o.M.a.C., Dietary Reference Intake: Folate, Other B Vitamins and Choline 1998 Washington, DC, USA National Academy Press
59. Association générations futures A, r.e.A.e.s.H., WWF-France,. Menus toxiques-Enquete sur les substances chimiques presentes dans notre alimentation: campagne Environnement cancer 2010
60. Narbonne, Sang pour sang toxique, 2010
61. Environmental Working Group, The Pollution in Newborns: A benchmark investigation of industrial chemicals, pollutants and pesticides in umbilical cord blood. edited by B. Burden, 2005
62. WHO, Malformations congénitales. Soixante-Troiseeéme Assemblée Mondiale de la Santé 2010 Geneva, Switzerland World Health Organization
63. Shah P. S., Ohlsson A., Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. Canadian Medical Association Journal 2009 180 12 E99 E108 2-s2.0-67649194404 10.1503/Canadian Medical Association Journal.081777
64. Zeng L., Cheng Y., Dang S., Yan H., Dibley M. J., Chang S., Kong L., Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial. British Medical Journal 2008 337, article a2001 2-s2.0-58149250666 10.1136/bmj.a2001
65. Chen G., Song X., Ji Y., Zhang L., Pei L., Chen J., Liu J., Li C., Zheng X., Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China. Birth Defects Research Part A 2008 82 8 592 596 2-s2.0-50249142280 10.1002/bdra.20471
66. Blencowe H., Cousens S., Modell B., Lawn J., Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology 2010 39 i110 121 2-s2.0-77951630647
67. Berry R. J., Bailey L., Mulinare J., Bower C., Fortification of flour with folic acid. Food and Nutrition Bulletin 2010 31 1 S22 S35 2-s2.0-77953071379
68. Adzick N. S., Thom E. A., Spong C. Y., Brock J. W., Burrows P. K., Johnson M. P., Howell L. J., Farrell J. A., Dabrowiak M. E., Sutton L. N., Gupta N., Tulipan N. B., D'Alton M. E., Farmer D. L., A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine 2011 364 11 993 1004 2-s2.0-79952810327 10.1056/NEJMoa1014379
69. Force, U.S.P.S.T., Folic acid for the prevention of neural tube defects: U.S. Preventive services task force recommendation statement. Annals of Internal Medicine 2009 150 9 626 631
70. Maberly G., Grummer-Strawn L., Jefferds M. E., Peña-Rosas J. P., Serdula M. K., Tyler V. Q., Berry R. J., Mulinare J., Parvanta I., Aburto N. J., Trends in wheat-flour fortification with folic acid and ironworldwide, 2004 and 2007. Morbidity and Mortality Weekly Report 2008 57 1 8 10
71. National Birth Defects Prevention Network, Neural tube defect ascertainment project 2010. 2010
72. Khoshnood B., Greenlees R., Loane M., Dolk H., Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Research Part A 2011 91 1 S16 S22 2-s2.0-79952683299 10.1002/bdra.20776
73. Prevention, C.f.D.C.a., Effectiveness in disease and injury prevention use of folic acid for prevention of spina bifida and other neural tube defects19831991. Morbidity and Mortality Weekly Report 1992 41 513 516
74. Bell K. N., Oakley G. P. Jr., Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research Part A 2009 85 1 102 107 2-s2.0-59849120166 10.1002/bdra.20504
75. Običan S. G., Finnell R. H., Mills J. L., Shaw G. M., Scialli A. R., Folic acid in early pregnancy: a public health success story. FASEB Journal 2010 24 11 4167 4174 2-s2.0-78649876711 10.1096/fj.10-165084
76. Mosley B. S., Cleves M. A., Siega-Riz A. M., Shaw G. M., Canfield M. A., Waller D. K., Werler M. M., Hobbs C. A., Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. American Journal of Epidemiology 2009 169 1 9 17 2-s2.0-58149229481 10.1093/aje/kwn331
77. Ahrens K., Yazdy M. M., Mitchell A. A., Werler M. M., Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology 2011 22 5 731 737 2-s2.0-79958066872 10.1097/EDE.0b013e3182227887
78. Yi Y., Lindemann M., Colligs A., Snowball C., Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. European Journal of Pediatrics 2011 170 11 1391 1400 2-s2.0-79955952694 10.1007/s00431-011-1492-8
79. Bruner J. P., Richards W. O., Tulipan N. B., Arney T. L., Endoscopic coverage of fetal myelomeningocele in utero. American Journal of Obstetrics and Gynecology 1999 180 1 I 153 158 2-s2.0-0032986194 10.1016/S0002-9378(99)70167-5 (Pubitemid 29088407)
80. Tulipan N., Bruner J. P., Myelomeningocele repair in utero: a report of three cases. Pediatric Neurosurgery 1998 28 4 177 180 2-s2.0-0031662886 (Pubitemid 28401992)
81. Adzick N. S., Sutton L. N., Crombleholme T. M., Flake A. W., Successful fetal surgery for spina bifida. Lancet 1998 352 9141 1675 1676 2-s2.0-0032556437 (Pubitemid 28526128)
82. Adzick N. S., Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention. Seminars in Fetal and Neonatal Medicine 2010 15 1 9 14 2-s2.0-74449089885 10.1016/j.siny.2009.05.002